All In Biotech

Drugs by condition

Drugs approved for hodgkin lymphoma

Brand-name prescription drugs and biologics whose FDA label lists hodgkin lymphoma as an approved use. Matched on the label phrases: "Hodgkin lymphoma".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

15

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

5

New molecular entities and new biologics

In development

36

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for hodgkin lymphoma.

All approved drugs for hodgkin lymphoma, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 31 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Programmed Death Receptor-1 Blocking Antibody (2)

  • Opdivo Nivolumab · Bristol Myers Squibb · 2014
  • Keytruda Pembrolizumab · Merck Sharp Dohme · 2014

CD30-directed Immunoconjugate (1)

  • Adcetris Brentuximab Vedotin · Seattle Genetics · 2011

Folate Analog Metabolic Inhibitor (1)

  • Jylamvo Methotrexate · Shorla · 2022

Class not listed in FDA's data (11)

Drugs in development for hodgkin lymphoma

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • FavezelimabMK-4280, MK-4820APhase 39 trials

    Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors

  • SurovatamigAZD0486, TNB-486Phase 39 trials

    AstraZeneca · B-cell Non-Hodgkin Lymphoma, Large B-cell Lymphoma, Untreated Follicular Lymphoma

  • CC-99282BMS-986369, GolcadomidePhase 37 trials

    Bristol Myers Squibb · Lymphoma, Follicular, Large B-cell Lymphoma, Non-Hodgkin Lymphoma

  • OdronextamabREGN1979, OrdsponoPhase 37 trials

    Regeneron · Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), Relapsed/Refractory Follicular Lymphoma

  • XNW5004EZH2iPhase 37 trials

    Evopoint Biosciences Inc. · Relapsed/Refractory Peripheral T Cell Lymphoma, Advanced Prostate Cancer, Follicular Lymphoma, Grade 1

  • TacabrutidegBGB-16673Phase 36 trials

    BeOne Medicines (BeiGene) · Chronic Lymphocytic Leukemia, B-cell Malignancy, Small Lymphocytic Lymphoma

  • AbexinostatPCI-24781Phase 35 trials

    Xynomic Pharmaceuticals, Inc. · Lymphoma, Follicular, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma

  • KRT-232NavtemadlinPhase 34 trials

    Kartos Therapeutics, Inc. · Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma

  • CobolimabPhase 32 trials

    GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma

  • Rondecabtagene autoleucelLYL314Phase 32 trials

    Lyell Immunopharma, Inc. · Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma

  • GNC-038Phase 24 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-hodgkin's Lymphoma, Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma

  • Relma-celCAR, CD19-targeted Chimeric Antigen Receptor T CellsPhase 23 trials

    Shanghai Ming Ju Biotechnology Co., Ltd. · Non-Hodgkin Lymphoma, Large B-cell Lymphoma, Multiple Myeloma

  • Zugocabtagene geleucelCTX112Phase 23 trials

    CRISPR Therapeutics AG · B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy

  • AB-101zabalafinPhase 22 trials

    Alphyn Biologics · Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis

  • AK129Phase 22 trials

    Akeso · Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma

  • AZD3470Phase 22 trials

    AstraZeneca · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

  • ImmunityBio, Inc. · Relapsed B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non Hodgkin Lymphoma

  • AT101Anti-CD19 Chimeric Antigen Receptor T cellPhase 21 trial

    AbClon · B-cell Non Hodgkin Lymphoma

  • AZD4512Phase 21 trial

    AstraZeneca · B-cell Non-Hodgkin Lymphoma

  • BMS-986458Phase 21 trial

    Bristol Myers Squibb · Relapsed/Refractory Non-Hodgkin Lymphoma

More on hodgkin lymphoma: recruiting trials · published research

Related in hematology and blood cancers: Multiple myeloma · Acute myeloid leukemia · Chronic lymphocytic leukemia · Acute lymphoblastic leukemia · Chronic myeloid leukemia · Lymphoma (non-Hodgkin) · Myelodysplastic syndromes · Myelofibrosis · Sickle cell disease · Hemophilia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.